Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
6 hedge funds and large institutions have $1.3M invested in Medigus Ltd. Series C Warrant in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
97% less capital inflows, than outflows
Capital inflows: $504 | Capital outflows: $14.5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$504 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$14.5K |
MDGSW Hedge Fund Activity: Q1 2021 in Review
6 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q1 2021, worth a combined $1.3M — up 8.8% from $1.2M a quarter earlier.
Fund positioning in MDGSW was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $504. The largest seller was Warberg Asset Management, cutting an estimated $14.5K.
- 6 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $1.3M of Medigus Ltd. Series C Warrant stock for Q1 2021, up 8.8% quarter-over-quarter.
- 0 funds opened new Medigus Ltd. Series C Warrant positions in Q1 2021 and 0 closed out.
- The largest Medigus Ltd. Series C Warrant buyer in Q1 2021 was UBS Group, an estimated $504 added.
- The largest Medigus Ltd. Series C Warrant seller in Q1 2021 was Warberg Asset Management, an estimated $14.5K sold.
Based on aggregated 13F filings for Q1 2021.